MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (A A H Pharmaceuticals Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Accord-UK Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Alliance Healthcare (Distribution) Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Crescent Pharma Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Glenmark Pharmaceuticals Europe Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Medihealth (Northern) Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Necessity Supplies Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Torrent Pharma (UK) Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Viatris UK Healthcare Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Incompatible

Zolmitriptan 2.5mg orodispersible tablets sugar free (Zentiva Pharma UK Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg orodispersible tablets sugar free suppliers

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Compatible with caution

Zolmitriptan 2.5mg tablets (A A H Pharmaceuticals Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Compatible with caution

Zolmitriptan 2.5mg tablets (Accord-UK Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Compatible with caution

Zolmitriptan 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Compatible with caution

Zolmitriptan 2.5mg tablets (Crescent Pharma Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Compatible with caution

Zolmitriptan 2.5mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Explore other Zolmitriptan formulations Explore other Zolmitriptan 2.5mg tablets suppliers

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Zomig 2.5mg tablets (Grunenthal Ltd).

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Compatible with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.